Targeting the Na(+)/H(+) exchanger: an old concept with new perspectives in the treatment of hematological malignancies.
Turturro
Francesco
F
Lawson
Michael
M
Friday
Ellen
E
Welbourne
Tomas
T
D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002839:Chromans / Q000494:pharmacology*; D019337:Hematologic Neoplasms / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D017923:Sodium-Hydrogen Exchangers / Q000187:drug effects* / Q000378:metabolism; D045162:Thiazolidinediones / Q000494:pharmacology*; D000077288:Troglitazone; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects / Q000378:metabolism
D000970:Antineoplastic Agents; D002839:Chromans; D017923:Sodium-Hydrogen Exchangers; D045162:Thiazolidinediones; D042461:Vascular Endothelial Growth Factor A; C069139:growth factor-activatable Na-H exchanger NHE-1; D000077288:Troglitazone